Market
Isomorphic Labs receives $2.1bn for AI drug development
The proceeds will be used to accelerate Isomorphic Labs’ pipeline of therapeutic programmes and further develop its IsoDDE AI drug design engine.
Was this article helpful?
Community
Loading comments...